Monday, May 15, 2023 8:00 AM – 11:30 AM ET Ballroom B
Major Symposium H
Immunity to Emerging Pathogens: COVID-19 and Beyond
Chairs
- James E. Crowe Jr., Vanderbilt Univ. Med. Ctr.
- Laura M. Walker, Moderna
Speakers
- James E. Crowe Jr., Vanderbilt Univ. Med. Ctr., Human monoclonal antibodies for emerging infections
- Laura M. Walker, Moderna, Evolution of antibody immunity following Omicron breakthrough infection
- Robert A. Seder, NIAID, NIH, Scientific and clinical development of monoclonal antibodies to prevent malaria
- Mark T. Esser, AstraZeneca, From the lab to the jab: lessons learned from the development of AstraZeneca’s long-acting antibody combination (Evusheld) for the prevention and treatment of COVID-19
- Amy L. Hartman, Univ. of Pittsburgh, Combating the threat of Rift Valley fever virus infection in utero
